Seaport Therapeutics
(NASDAQ) SPTX
Seaport Therapeutics Financials at a Glance
Market Cap
$975.86MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$38.53
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
4.05 (High)
Dividend
$0.00
Beta (Volatility)
4.05 (High)
Price
$21.16
Volume
223,384
Open
$18.17
Price
$21.16
Volume
223,384
Open
$18.17
Previous Close
$21.26
Daily Range
$17.89 - $21.59
52-Week Range
$14.85 - $23.00
Estimated Earnings Date
Sep 14, 2026
Dividend
$0.00
Beta (Volatility)
4.05 (High)
Price
$21.16
Volume
223,384
Open
$18.17
Previous Close
$21.26
Daily Range
$17.89 - $21.59
52-Week Range
$14.85 - $23.00
Estimated Earnings Date
Sep 14, 2026
SPTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Seaport Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
58
CEO
Daphne Zohar
Website
www.seaporttx.comHeadquarters
Boston, MA 02210-2186, US
SPTX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
80.91%
Return on Capital
N/A
Return on Assets
-30.07%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$975.86MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
53.53M
Volume
223.38K
Avg. Volume
380.08K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$27.54M
EBITDA
-$27.19M
Operating Cash Flow
-$20.17M
Capital Expenditure
$0.00
Free Cash Flow
-$20.17M
Cash & ST Invst.
$182.61M
Total Debt
$5.34M
Seaport Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$975.86MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$16.83M
N/A
Employees
58
N/A
Net Income
-$25.41M
N/A
EBITDA
-$27.19M
N/A
Quarterly Fundamentals
Total Cash
$182.61M
N/A
Total Debt
$5.34M
N/A
Accounts Receivable
$3.28M
N/A
Inventory
$0.00
N/A
Long Term Debt
$3.74M
N/A
Short Term Debt
$1.60M
N/A
Return on Assets
-30.07%
N/A
Return on Invested Capital
-36.95%
N/A
Free Cash Flow
-$20.17M
N/A
Operating Cash Flow
-$20.17M
N/A